Paul Dent

Affiliations: 
Biochemistry Virginia Commonwealth University, Richmond, VA, United States 
Area:
Biochemistry, Cell Biology
Google:
"Paul Dent"
Mean distance: (not calculated yet)
 

Children

Sign in to add trainee
Clint Mitchell grad student 2006 VCU
Aditi P. Martin grad student 2009 VCU
Teneille D. Walker grad student 2009 VCU
Mary D. Bareford grad student 2012 VCU
Hossein A. Hamed grad student 2012 VCU
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Booth L, Poklepovic A, Dent P. (2019) Not the comfy chair! Cancer drugs that act against multiple active sites. Expert Opinion On Therapeutic Targets
Booth LA, Roberts JL, Dent P. (2019) The role of cell signaling in the crosstalk between autophagy and apoptosis in the regulation of tumor cell survival in response to sorafenib and neratinib. Seminars in Cancer Biology
Dent P, Booth L, Poklepovic A, et al. (2019) Signaling alterations caused by drugs and autophagy. Cellular Signalling. 109416
Booth L, Roberts JL, Poklepovic A, et al. (2019) Correction: HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody . Oncotarget. 10: 5120-5122
Booth L, Roberts JL, Cruickshanks N, et al. (2019) Editor's Note: Regulation of OSU-03012 Toxicity by ER Stress Proteins and ER Stress-Inducing Drugs. Molecular Cancer Therapeutics. 18: 1669
Booth L, Roberts JL, Poklepovic A, et al. (2019) The Lethality of [Pazopanib + HDAC Inhibitors] Is Enhanced by Neratinib. Frontiers in Oncology. 9: 650
Dent P, Booth L, Roberts JL, et al. (2019) Neratinib inhibits Hippo/YAP signaling, reduces mutant K-RAS expression, and kills pancreatic and blood cancer cells. Oncogene
Dasmahapatra G, Lembersky D, Son MP, et al. (2019) Retraction: Obatoclax Interacts Synergistically with the Irreversible Proteasome Inhibitor Carfilzomib in GC- and ABC-DLBCL Cells and . Molecular Cancer Therapeutics. 18: 1180
Dasmahapatra G, Lembersky D, Son MP, et al. (2019) Retraction: Carfilzomib Interacts Synergistically with Histone Deacetylase Inhibitors in Mantle Cell Lymphoma Cells and . Molecular Cancer Therapeutics. 18: 1179
Dasmahapatra G, Nguyen TK, Dent P, et al. (2019) Corrigendum to "Adaphostin and bortezomib induce oxidative injury and apoptosis in imatinib mesylate-resistant hematopoietic cells expressing mutant forms of Bcr/Abl" [Leuk. Res. 30 (2006) 1263-1272]. Leukemia Research
See more...